A researcher from UAB and four colleagues found in a study that product proliferation, a commonly used marketing tactic, may not work for all brands or products, depending on the brand relevance in the product’s category.
This transport system may be widespread across many Gram-positive bacteria that contain proteins in the WXG100 superfamily. Tuberculosis kills 1 million people each year.
Using spatial transcriptomics, UAB researchers set out to understand the differences and similarities between two viral infections causing acute lung injury, as it could improve patient care, as well as identify novel therapeutic targets.
Heart failure is a leading cause of death in the United States. Highly effective medications are now available, and the disease is manageable if patients seek care and take their prescribed medications regularly.
A study conducted by UAB investigators found that the newly recommended scores are very effective in diagnosing a type of heart failure that is challenging to detect, and can also help predict patients’ long-term outcomes.
Many patients have been struggling to pay for their treatment, and the financial consequences can affect a person’s emotional well-being. This collaborative effort will recruit researchers nationwide to help solve these issues.
In a study of more than 6,000 American adults, UAB investigators found that those with a coronary artery calcium score greater than zero have a higher risk of cardiac events. CAC may help guide blood pressure control and comprehensive cardiovascular care.
Researchers find a role for citrullinated vimentin as a damage-associated molecular pattern molecule, or DAMP, that is generated by lung macrophages in response to environmental cadmium/carbon black.
The study points to an adhesive cell surface protein that might be a key element in tackling the resistance to radiation therapy commonly seen in glioblastoma tumors.
Alabama and the Southeast have high rates of kidney disease, especially in minority populations. On World Kidney Day, physicians have a chance to shine a light on this troublesome disease.
UAB researchers Jerzy Szaflarski, M.D., Ph.D., and Ayushe Sharma, Ph.D., won for their study of whether taking cannabidiol oil for seizures affects structures in the brain.
The list was made by a group that aspires to bolster and increase diversity across all scientific fields, promote retention through the “leaky academic pipeline,” and broaden academic and industrial awareness of diversity and inclusion.
Suzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.
Preclinical tests at UAB last year showed potent systemic and mucosal immune responses in mice after a single intranasal dose. The vaccine candidate was developed by Maryland-based Altimmune Inc.
Research found that gaining community members’ perspectives to identify barriers and facilitators to COVID-19, related to prevention, coping and testing, may potentially improve outcomes.
Altered epigenetic marks on ribosomal RNAs appear to create a pool of specialized ribosomes that can differentially regulate translation of specific messenger RNA.
Ben McManus’ proposal to research the understudied relationship between resident well-being and work organization factors wins a distinguished NIOSH K01 grant.
The 72-year-old patient was unable to mount her own immune defense against the SARS-CoV-2 virus because of chronic lymphocytic leukemia, which compromises normal immunity and immunoglobulin production.
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.